Document and Entity Information Entity Addresses [Table] Entity Addresses [Line Items] Document Type Document Annual Report Document Period End Date Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Entity Shell Company Entity Shell Company Entity Public Float Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Auditor Name Auditor Firm ID Auditor Location CONSOLIDATED BALANCE SHEETS Assets [Abstract] ASSETS Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Prepaid Expense, Current Prepaid expenses and deposits Other Receivables, Net, Current Other receivables Assets, Current Total current assets Assets Total assets Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities, Current [Abstract] Current liabilities: Accounts Payable and Accrued Liabilities, Current Accounts payable and accrued liabilities Due to Related Parties, Current Related party payable Other Liability, Current, Related Party, Type [Extensible Enumeration] Liabilities, Current Total current liabilities Liabilities Total liabilities Stockholders' Equity Attributable to Parent [Abstract] Stockholders' equity: Preferred Stock, Value, Issued Preferred stock, $0.001 par value, 5 million shares authorized, 0 shares issued and outstanding at December 31, 2024 and 2023, respectively Common Stock, Value, Issued Common stock, $0.001 par value, 30 million shares authorized, 10.7 million and 8.9 million shares issued and outstanding as of December 31, 2024 and 2023, respectively (see Note 8) Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders' Equity Attributable to Parent Ending Balance Beginning Balance Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Statement [Table] INCOME TAXES Statements Statement Preferred Stock, Par or Stated Value Per Share Preferred stock par value (in $ per share) Preferred Stock, Shares Authorized Preferred stock authorized (in shares) Preferred Stock, Shares Issued Preferred stock issued Preferred Stock, Shares Outstanding Preferred stock outstanding Common Stock, Par or Stated Value Per Share Common stock par value (in $ per share) Common Stock, Shares Authorized Common stock authorized (in shares) Common Stock, Shares, Issued Common stock issued Common Stock, Shares, Outstanding Common stock outstanding CONSOLIDATED STATEMENTS OF OPERATIONS Product and Service [Axis] Product and Service [Domain] Grant [Member] Grant income Revenues [Abstract] Revenues: Revenue from Contract with Customer, Including Assessed Tax Revenue recognized Total revenues Costs and Expenses [Abstract] Operating expenses: Research and Development Expense Research and development General and Administrative Expense General and administrative Operating Expenses Total operating expenses Operating Income (Loss) Loss from operations Nonoperating Income (Expense) [Abstract] Other income (expenses): Investment Income, Interest Interest income Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss from continuing operations before income taxes Income Tax Expense (Benefit) Income tax expense Income tax provision/(benefit) Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Loss from continuing operations Net loss from continuing operations No definition available. Discontinued Operation, Income (Loss) from Discontinued Operation [Abstract] Discontinued operations: Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax Loss from discontinued operations Loss from discontinued operations Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax Gain on disposal of discontinued operations, net of $63,000 in tax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Income (loss) from discontinued operations Income (loss) from discontinued operations Less: gain from discontinued operations, net of $63,000 in tax Net loss Net loss Earnings Per Share [Abstract] Net earnings (loss) per share: Net earnings (loss) per share: Income (Loss) from Continuing Operations, Per Basic Share Loss from continuing operations, basic (in dollars per share) Income (Loss) from Continuing Operations, Per Diluted Share Loss from continuing operations, diluted (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share Income from discontinued operations, basic (in dollars per share) Income (loss) from discontinued operations, basic (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share Income from discontinued operations, diluted (in dollars per share) Income (loss) from discontinued operations, diluted (in dollars per share) Earnings Per Share, Basic Net loss per share, basic (in dollars per share) Earnings Per Share, Diluted Net loss per share, diluted (in dollars per share) Earnings Per Share, Basic, Other Disclosure [Abstract] Weighted average number of common shares outstanding: Weighted Average Number of Shares Outstanding, Basic Weighted average number of common shares outstanding, basic (in shares) Weighted average common shares outstanding, basic Weighted Average Number of Shares Outstanding, Diluted Weighted average number of common shares outstanding, diluted (in shares) Weighted average common shares outstanding, diluted Discontinued Operation, Tax Effect of Gain (Loss) from Disposal of Discontinued Operation Tax on gain on disposal of discontinued operations Gain from discontinued operations, net of tax CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Common Stock Additional Paid-in Capital [Member] Additional Paid-in Capital Retained Earnings [Member] Accumulated Deficit Shares, Issued Ending Balance, Shares Beginning Balance, Shares Stock Issued During Period, Value, New Issues Shares purchased pursuant to ATM agreement Aggregate proceeds from shares issued under the purchase agreement Stock Issued During Period, Shares, New Issues Shares purchased pursuant to ATM agreement (in shares) Number of shares issued (in shares) It represents value of common stock as commitment fee for future financing. Issuance Of Common Stock , Value, As Commitment Fee For Future Financing Issuance of common stock as commitment fee It represents number of common stock issued as commitment fee for future financing. Issuance Of Common Stock, Shares, As Commitment Fee For Future Financing Issuance of common stock as commitment fee (in shares) Stock Issued During Period, Value, Stock Options Exercised Issuance of common stock from exercise of stock options Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Number of Shares, Exercised Issuance of common stock from exercise of stock options (in shares) Issuance of common stock from exercise of stock options (in shares) Equity impact of the value of new stock and warrants to purchase common stock issued during the reporting period. Includes shares issued in an initial public offering or a secondary public offering. Stock And Warrants Issued During Period, Value, New Issues Issuance of common stock, prefunded warrants and warrants for cash, net of offering costs of $1.2 million Number of new stock and warrants to purchase common stock issued during the reporting period. Stock And Warrants Issued During Period, Shares, New Issues Issuance of common stock, prefunded warrants and warrants for cash, net of offering costs of $1.2 million (in shares) Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Stock-based compensation Reduction in the number of shares during the period as a result of a fractional shares adjustment due to reverse split. Stock Issued During Period, Shares, Fractional Shares Adjustment Due to Reverse Split Fractional shares adjustment due to reverse split Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Net of offering costs CONSOLIDATED STATEMENTS OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities [Abstract] Cash Flows from Operating Activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Net loss from continuing operations Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Reconciliation of net loss to net cash used in operating activities: Share-Based Payment Arrangement, Noncash Expense Stock-based compensation Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Prepaid Expense Prepaid expenses and deposits Increase (Decrease) in Accrued Interest Receivable, Net Other receivables Increase (Decrease) in Due to Related Parties, Current Related party payable Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash used in operating activities - continuing operations Cash Provided by (Used in) Operating Activities, Discontinued Operations Net cash used in operating activities - discontinued operations Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash Flows from Investing Activities: Cash Provided by (Used in) Investing Activities, Discontinued Operations Net cash provided by investing activities - discontinued operations Net cash provided by investing activities Net Cash Provided by (Used in) Investing Activities Net cash provided by investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash Flows from Financing Activities: The net cash inflow, after issuance costs associated with the amount received from issuance of common stock and from issuance of rights to purchase common shares at predetermined price during the reporting period. Proceeds from Issuance of Common Stock And Warrants, Net Proceeds from issuance of common stock, prefunded warrants and warrants, net Proceeds from Stock Options Exercised Proceeds from stock options exercise Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Net increase in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash and cash equivalents at end of the year Cash and cash equivalents at beginning of the year Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental schedule of non-cash financing and investing activities: The value of Issuance of common stock as commitment fee for future financing. Non Cash Issuance Of Common Stock As Commitment Fee For Future Financing Issuance of common stock as commitment fee for future financing NATURE OF OPERATIONS Nature of Operations [Text Block] NATURE OF OPERATIONS n/a FINANCIAL CONDITION, GOING CONCERN AND MANAGEMENT PLANS Liquidity Financial Condition And Going Concern Text Block Liquidity Financial Condition And Going Concern [Text Block] FINANCIAL CONDITION, GOING CONCERN AND MANAGEMENT PLANS SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] SIGNIFICANT ACCOUNTING POLICIES NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDERS Noncontrolling Interest Disclosure [Text Block] NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDERS OTHER RECEIVABLE Loans, Notes, Trade and Other Receivables Disclosure [Text Block] OTHER RECEIVABLE DISCONTINUED OPERATIONS Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] DISCONTINUED OPERATIONS ACCOUNTS PAYABLE, ACCRUED LIABILITIES, AND RELATED PARTY PAYABLE Accounts Payable and Accrued Liabilities Disclosure [Text Block] ACCOUNTS PAYABLE, ACCRUED LIABILITIES, AND RELATED PARTY PAYABLE STOCKHOLDERS' EQUITY Stockholders' Equity Note Disclosure [Text Block] STOCKHOLDERS' EQUITY STOCK BASED COMPENSATION Disclosure of Compensation Related Costs, Share-based Payments [Text Block] STOCK BASED COMPENSATION GRANT INCOME Revenue from Contract with Customer [Text Block] GRANT INCOME COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] COMMITMENTS AND CONTINGENCIES RELATED PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] RELATED PARTY TRANSACTIONS INCOME TAXES Income Tax Disclosure [Text Block] INCOME TAXES SUBSEQUENT EVENTS Subsequent Events [Text Block] SUBSEQUENT EVENTS Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Consolidation, Policy [Policy Text Block] Principles of Consolidation Use of Estimates, Policy [Policy Text Block] Use of Estimates Cash and Cash Equivalents, Policy [Policy Text Block] Cash, Cash Equivalents and Credit Risk Discontinued Operations, Policy [Policy Text Block] Discontinued Operations Intangible Assets, Finite-Lived, Policy [Policy Text Block] Patents and Patent Application Costs Share-Based Payment Arrangement, Director [Policy Text Block] Stock-Based Compensation Research and Development Expense, Policy [Policy Text Block] Research and Development Costs Income Tax, Policy [Policy Text Block] Income Taxes Disclosure of accounting policy for grant income. Grant Income, Policy [Policy Text Block] Grant Income Earnings Per Share, Policy [Policy Text Block] Loss per Common Share Segment Reporting, Policy [Policy Text Block] Segment Reporting New Accounting Pronouncements, Policy [Policy Text Block] New Accounting Standards Disclosure of accounting policy for recently issued accounting standards adopted. Recently Issued Accounting Standards Adopted [Policy Text Block] Recently Adopted Accounting Standards Disclosure of accounting policy for recently issued accounting standards not yet adopted. Recently Issued Accounting Standards Not yet Adopted [Policy Text Block] Recently Issued Accounting Standards Not Yet Adopted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of computation of net loss per share Tabular disclosure of net loss per share. Net Loss Per Share [Table Text Block] Schedule of anti-dilutive securities Disposal Groups, Including Discontinued Operations [Table Text Block] Schedule of income statement information and summary of cash flows for discontinued operations Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of accounts payable, accrued liabilities, and related party payable Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Summary of warrants outstanding This table lists the stock-based compensation. Stock-Based Compensation [Table] Line items represent stock-based compensation. Stock-Based Compensation [Line Items] STOCK-BASED COMPENSATION Share-based Payment Arrangement, Activity [Table Text Block] Schedule of the company's stock option activity Schedule or Description of Weighted Average Discount Rate [Table Text Block] Schedule of weighted average assumptions used in calculating the fair values of stock options that were granted Tabular disclosure of stock based compensation expenses recorded. Stock based Compensation Expenses [Table Text Block] Schedule of stock-based compensation expenses Schedule of Related Party Transactions [Table Text Block] Schedule of related party transaction expenses Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of deferred tax assets Tabular disclosure of expected tax expense benefit based on federal statutory rate is reconciled with actual tax provision benefit. Summary Of Expected Tax Expense Benefit Based On Federal Statutory Rate is Reconciled With Actual Tax Provision Benefit [Table Text Block] Schedule of expected tax expense (benefit) from continuing operations Disclosure of information about organization, consolidation and presentation of financial statements. Organization, Consolidation and Presentation of Financial Statements Type of Arrangement and Non-arrangement Transactions [Axis] Arrangements and Non-arrangement Transactions [Domain] Represents the information pertaining to Cell Ready Agreement. Cell Ready Agreement [Member] Cell Ready Purchase Agreement Disposal Group Classification [Axis] Disposal Group Classification [Domain] Discontinued Operations, Disposed of by Sale [Member] Disposed by sale Discontinued Operations, Disposed of by Sale Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Organization, Consolidation and Presentation of Financial Statements [Line Items] NATURE OF OPERATIONS Disposal Group, Including Discontinued Operation, Consideration Consideration for purchased assets Consideration for purchased assets The number of employees extended for employment. Offers Employment to Number of Employees Number of former employees offered employment Severance Costs Severance and termination-related costs Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed. Financial Condition Going Concern And Management Plans [Table] Represents the information pertaining to controlled equity offering sales agreement. Controlled Equity Offering Sales Agreement [Member] ATM Agreement This member stands for binding services agreement. Binding Services Agreement [Member] Binding Services Agreement Counterparty Name [Axis] Counterparty Name [Domain] Represents the information pertaining to Cantor Fitzgerald & Co and RBC Capital Markets, LLC. Cantor Fitzgerald Co. And Rbc Capital Markets Llc [Member] Sales Agents Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent event Related Party [Axis] Related Party [Domain] The information pertaining to Lincoln Park. Lincoln Park [Member] Lincoln Park This member represents information pertaining to National Institutes of Health Small Business Innovation Research. National Institutes of Health Small Business Innovation Research [Member] SBIR grant Represents information pertaining to grants from National Institutes of Health-National Cancer Institute. National Institutes of Health National Cancer Institute Grant [Member] National Institutes of Health National - Cancer Institute Grant Represents information pertaining to grant from National Institutes of Health and Business Innovation research for Lymphoma. National Institutes of Health Small Business Innovation Research For Lymphoma Grant [Member] SBIR lymphoma grant Represents information pertaining to grant from National Institutes of Health and Business Innovation research for pancreatic cancer. National Institutes of Health Small Business Innovation Research For Pancreatic Cancer [Member] SBIR pancreatic cancer grant National Institutes of Health Small Business Innovation Research For Pancreatic Cancer Award of money not required to be repaid for FDA grant. FDA Grant [Member] FDA grant Award of money not required to be repaid for additional CPRIT grant. Additional CPRIT Grant [Member] Additional CPRIT grant Sale of Stock [Axis] Sale of Stock [Domain] Private Placement [Member] Private Placement Represents information pertaining to At The Market Offering. At The Market Offering [Member] Market Offering Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Represents information pertaining to pre-funded warrants. Pre Funded Warrant [Member] Pre Funded Warrant Represents information pertaining to private placement warrants. Private Placement Warrant [Member] Private Placement Warrant Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. FINANCIAL CONDITION, GOING CONCERN AND MANAGEMENT PLANS [Line Items] FINANCIAL CONDITION, GOING CONCERN AND MANAGEMENT PLANS Common Stock, Value, Subscriptions Aggregate offering price Represents the percent of calculation of compensation rate by using gross sales price per share sold. Common Stock, Shares, Commission Rate Calculation on Gross Sales Price per Share, Percent Commission rate Proceeds from Issuance of Common Stock Proceeds from Issuance of Common Stock Proceeds from issuance of common stock, net Research and Development Arrangement, Contract to Perform for Others, Compensation Earned Amount of notice received Funds received from grant. Funds Received From CPRIT Grant Funds received from CPRIT grant Revenue from grant related to CPRIT. Revenue From Grant Related to CPRIT Revenue from CPRIT Funds received from grant Funds Received From Grant Funds received from grant Amount of grant income transfer product and service to customer for which consideration has been received or is receivable. Grant Received Grant income received Amount of receivable from Orphan Products Grant program. Orphan Products Grant Program Grant income receivable Grants Receivable Grant receivable Duration of grant assistance transaction, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Grant Assistance Term Grant Assistance Term Stock Issued During Period, Value, Other Stock issued during period other Stock Issued During Period, Shares, Other Stock issued during period other (in shares) Represents the amount of commitment fees. Commitment Fee Commitment fee Class of Warrant or Right, Number of Securities Called by Warrants or Rights Issuance of shares of common stock Shares Issued, Price Per Share Purchase price Sale of Stock, Consideration Received on Transaction Net proceeds from the sale of securities Cash, FDIC Insured Amount Cash, FDIC insured amount The amount of cash held at financial institutions. Cash at Financial Institutions Cash at financial institutions US Government Agencies Securities, at Carrying Value Government agency securities Unrecognized Tax Benefits Unrecognized tax benefits Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Interest or penalties Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDERS Net Income (Loss) Attributable to Parent, Diluted [Abstract] Numerator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Denominator: Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Warrant [Member] Common stock purchase warrants Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Potentially dilutive securities Schedule of Receivables with Imputed Interest [Table] Project [Axis] Project [Domain] The information pertaining to cancer Prevention And Research Institute Of Texas. Cancer Prevention And Research Institute Of Texas [Member] CPRIT Receivables with Imputed Interest [Line Items] OTHER RECEIVABLE Amount of revenue recognized for grant from Orphan Products Grant program. Revenue From Orphan Products Grant Program Grant revenue Disposal Groups, Including Discontinued Operations [Table] Service [Member] Service Revenue This member stands for related party service. Related Party Service [Member] Related party service revenue Income Statement Location [Axis] Income Statement Location [Domain] Research and Development [Member] Research and development General and Administrative [Member] General and administrative Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] DISCONTINUED OPERATIONS Disposal Group, Including Discontinued Operation, Revenue Total revenues Disposal Group, Including Discontinued Operation, Operating Expense Total operating expenses Net Cash Provided by (Used in) Discontinued Operations Net increase in cash and cash equivalents from discontinued operations Related Party [Member] Related party Represents information pertaining to Clinical Trial Agreement with Wilson Wolf Manufacturing Corporation. Wilson Wolf Manufacturing Corporation [Member] Wilson Wolf Manufacturing Corporation Disposal Group, Including Discontinued Operation, Liabilities Liabilities classified in discontinued operations Disposal Group, Including Discontinued Operation, Assets Assets classified in discontinued operations Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax Gain on disposal of discontinued operations before income taxes Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration] The amount of cash payment. Cash Payment Other Operating Income Agreement amount on cash payment The amount of additional cash payment. Additional cash payment Additional cash payment This table lists the accounts payable and accrued liabilities. The line items identify information about the accounts payable and accrued liabilities. Accounts Payable And Accrued Liabilities [Table] Represents the information pertaining to Cell Ready. Cell Ready [Member] Cell Ready Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Accounts Payable And Accrued Liabilities [Line Items] ACCOUNTS PAYABLE, ACCRUED LIABILITIES, AND RELATED PARTY PAYABLE Accounts Payable, Current Accounts payable Employee-related Liabilities, Current Compensation and benefits Accrued Professional Fees, Current Professional fees The amount of tax fees payable. Tax Fees Payable Tax fees Other Accrued Liabilities, Current Other Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. Accounts Payable and Accrued Liabilities Including Related party payable, Current Total accounts payable and accrued liabilities Schedule of Stock by Class [Table] Class of Stock [Line Items] STOCKHOLDERS' EQUITY Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] This Member represents stock purchase agreement Stock Purchase Agreement [Member] Stock Purchase Agreement The member stands for ATM agreement. ATM Agreement [Member] ATM Agreement Subsidiary, Sale of Stock [Line Items] STOCKHOLDERS' EQUITY The time to time term to purchase shares in stock purchase agreement, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Stock Purchase Agreement, Time to Time Term to Purchase Shares Time to time term to purchase shares (in months) Class of Warrant or Right [Table] Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise Price Per Share Warrants and Rights Outstanding, Term Warrants Expiration term Class of Warrant or Right, Outstanding Outstanding at the end Outstanding at the beginning Number of warrants or rights issued by the entity during the reporting period. Class of Warrant or Right, New Issuance New Issuance Option Indexed to Issuer's Equity, Type [Axis] Option Indexed to Issuer's Equity, Type [Domain] Title of Individual [Axis] Relationship to Entity [Domain] Executive officer [Member] Executive officer Represents the information pertaining to non-executive employees. Non-executive Employees [Member] Non-executive employees Chief Executive Officer, President and Chairman [Member] Chief Executive Officer, President and Chairman Represents member information pertaining to 2023 equity incentive plan. Equity Incentive Plan 2023 [Member] 2023 Equity Incentive Awards Grantee Status [Axis] Grantee Status [Domain] Employees [Member] Employees Non-Employee [Member] Non employee Plan Name [Axis] Plan Name [Domain] Represents member information pertaining to 2020 equity incentive plan. Equity Incentive Plan 2020 [Member] 2020 Equity Incentive Plan Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of Shares Outstanding, Ending Balance Number of Shares Outstanding, Beginning Balance Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Number of Shares, Granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Number of Shares, Cancelled / Expired Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Number of Shares, Options vested and exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted Average Exercise Price per Share, Outstanding, Ending Balance Weighted Average Exercise Price per Share, Outstanding, Beginning Balance Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Exercise price of options granted Weighted Average Exercise Price per Share, Granted Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted Average Exercise Price per Share, Exercised Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted Average Exercise Price per Share, Cancelled / Expired Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted Average Exercise Price, Options vested and exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Total Intrinsic Value Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Total Intrinsic Value, Options vested and exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Life, Outstanding (in years) Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Share-based Compensation Arrangement by Share-based Payment Award, Options, Granted in Period, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Life, Options granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Life, Options vested and exercisable (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price Exercise price Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected term (years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected stock price volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free rate of interest Amount of expense for Stock compensation in continuing operations. Stock Compensation In Continuing Operations Stock compensation in continuing operations Amount of expense for Stock compensation in discontinued operations. Stock Compensation In Discontinued Operations Stock compensation in discontinued operations Allocated Share-based Compensation Expense Total stock compensation expenses Represents information pertaining to 2024 equity incentive awards. Equity Incentive Award 2024 [Member] 2024 Equity Incentive Awards This member stands for Loss from discontinued operations. Loss From Discontinued Operations [Member] Loss from discontinued operations. Independent members of the board of directors [Member] Director Vesting [Axis] Vesting [Domain] Share-Based Payment Arrangement, Tranche One [Member] Tranche one Share-Based Payment Arrangement, Tranche Two [Member] Tranche two Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Total stock-based compensation cost related to unvested awards not yet recognized Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Expected weighted average period of recognition of unrecognized compensation costs (in years) Expiration period Expiration period Number of equal monthly installments for option award vesting over the vesting period. Number of Equal Monthly Installments for Vesting of Awards Number of equal monthly installments of award Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Award vesting period Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Number of options to purchase shares Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Vesting percentage Share based compensation arrangement number of share options available for issued. Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Options Available for Issued Number of shares options available to be issued Share-Based Payment Arrangement, Plan Modification, Incremental Cost Incremental stock-based compensation expense in connection with the termination of certain employees This table lists the grant income. Grant Income [Table] Award of money not required to be repaid for CPRIT grant. CPRIT Grant [Member] CPRIT grant Line items represents grant income. Grant Income [Line Items] GRANT INCOME Receipt of product development research award Receipt Of Product Development Research Award Receipt of product development research award Restricted Cash Restricted cash recorded Commitments And Contingencies [Table] Represents information pertaining to the grant agreement with Cancer Prevention and Research Institute Of Texas ("CPRIT"). Cancer Prevention And Research Institute Of Texas Grant Agreement [Member] Cancer Prevention and Research Institute of Texas Represents information pertaining to the exclusive license agreement with Baylor College of Medicine ("BCM"). Baylor College Of Medicine License Agreement [Member] License agreement with Baylor College of Medicine Commitments And Contingencies [Line Items] COMMITMENTS AND CONTINGENCIES The percentage of net sales of any product to the grants received by the entity for which payments have to be made as per the terms of the grant agreement. Grant Agreement, Payments Required, Percentage Of Net Sales To Grants Received Aggregate amount (in Percentage) The percentage of revenue sharing by the entity with the counter party for the remainder revenue term as per the terms of the grant agreement. Grant Agreement, Revenue Sharing Percentage, Remainder of Revenue Term Revenue sharing percentage The value of shares issued or sold by the entity for the stock transaction during the reporting period. Sale of Stock, Value of Shares Issued in Transaction Shares issued in common stock value The aggregate amount of the milestone payments agreed to be paid by the entity as per the terms of the license agreement. License Agreement, Maximum Milestone Payments Agreed To Be Paid Milestone payments agreed The percentage of the liquidity event proceeds that will be paid as a one-time liquidity incentive payment by the entity as per the terms of the license agreement. License Agreement, Liquidity Incentive Payment Percentage Liquidity incentive payment in percentage Schedule of Related Party Transactions, by Related Party [Table] Represents information pertaining to Clinical Trial Agreement with Baylor College of Medicine. Clinical Trial Agreement with Baylor College of Medicine [Member] Baylor College of Medicine Related Party Transaction [Line Items] RELATED PARTY TRANSACTIONS Related Party Transaction, Expenses from Transactions with Related Party Total Research and development The term of the master services agreement entered into by the entity, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Master Services Agreement, Term Master Services Agreement Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization Service and manufacturing costs Invoices for the cost of product sold and service rendered, excluding depreciation, depletion, and amortization. Invoices Received for Services and Manufacturing Costs Paid invoices Deferred Income Taxes and Other Assets [Abstract] Deferred Tax Assets Deferred Tax Assets, Operating Loss Carryforwards Net Operating Loss Carryforward Deferred tax stock based compensation. Deferred tax stock based compensation Stock Compensation Deferred Tax Assets, in Process Research and Development Capitalized R&E Deferred Tax Assets, Tax Credit Carryforwards, Research Research and Development Deferred Tax Assets, Gross Deferred Tax Assets Deferred Tax Assets, Valuation Allowance Less: Valuation Allowance Deferred Tax Assets, Net of Valuation Allowance Total Deferred Tax Assets Deferred Tax Assets, Net Net Deferred Tax Assets/(Liabilities) Tax Credit Carryforward [Axis] Tax Credit Carryforward, Name [Domain] Research Tax Credit Carryforward [Member] Research and development Income Tax Authority [Axis] Income Tax Authority [Domain] Foreign Tax Authority [Member] Foreign tax authority State and Local Jurisdiction [Member] State and local jurisdiction Income Tax [Line Items] Income Tax [Line Items] INCOME TAXES Current Federal Tax Expense (Benefit) Federal income tax expense Current State and Local Tax Expense (Benefit) State tax expense Deferred Tax Assets, Operating Loss Carryforwards, Foreign Deferred tax assets, operating loss carryforwards, foreign Deferred Tax Assets, Operating Loss Carryforwards, State and Local Deferred tax assets, operating loss carryforwards, state and local Tax credit carryforward expiration year range start. Tax credit carry forward expiration year range start Tax credit carryforwards expiration period Tax credit carryforward expiration year range end. Tax credit carry forward expiration year range end Tax credit carryforwards expiration year end Operating Loss Carryforwards Operating loss carryforwards The percentage of limitation for operating loss carryforwards Operating Loss Carryforwards Limitation Percentage Operating loss carryforwards limitation percentage Tax Credit Carryforward, Amount Tax credit carryforwards Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount U.S. federal statutory rate Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount State taxes, net of federal benefit Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount Tax rate change Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent U.S. federal statutory rate, Percent Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent State taxes, net of federal benefit, Percent Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Tax rate change, Percent Effective Income Tax Rate Reconciliation, Amount [Abstract] Permanent Differences Permanent differences other permanent differences. Permanent differences other permanent differences Permanent differences- Other permanent differences Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Change in valuation allowance Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to deferred tax true-up adjustments. Effective Income Tax Rate Reconciliation, Deferred Tax True Up Adjustment, Amount Deferred true-up Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Other Represents the effective tax rate reconciliation due to other permanent differences. Effective Income Tax Rate Reconciliation Other Permanent Differences Permanent differences- Other permanent differences, Percent Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Change in valuation allowance, Percent Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to deferred tax true-up adjustments. Effective Income Tax Rate Reconciliation, Deferred Tax True Up Adjustment, Percent Deferred true-up, Percent Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Other, Percent Effective Income Tax Rate Reconciliation, Percent Income tax provision (benefit), Percent Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Unrecognized tax benefits income tax penalties and interest accrued Subsequent Event [Table] Represents information pertaining to Series A Warrants. SeriesA Warrants [Member] Series A Warrants Represents information pertaining to Series B Warrants. Series B Warrants [Member] Series B Warrants Subsequent Event [Line Items] Subsequent Events Amount of cash outflows on termination of agreement. Payments On Termination Of Agreement Payments on termination of agreement